Weei-Chin Lin

Weei-Chin Lin is a Professor at Baylor College of Medicine, affiliated with the Department of Medicine and cross-appointed to the Department of Molecular & Cellular Biology and Duncan Cancer Center. His research focuses on Cancer Biology, Molecular Biology, and Biochemistry, particularly mechanisms of DNA damage response, oncogenic pathways, and therapeutic targeting.

Selected publications highlight work on TopBP1 in cancer, PARP inhibitors, EGFR regulation, and 14-3-3 proteins. Key themes include synthetic lethality, checkpoint control, ubiquitination, and metastasis mechanisms.

Scientific awards include NIH grants,

• NIH BCO Study Section member (2025-2029)
• Cancer Center pilot awards
• Leukemia & Lymphoma Society Scholar (2006-2011)

His work bridges translational oncology and molecular mechanisms, with clinical implications for chemotherapy resistance and novel cancer therapies.